Target- |
Mechanism- |
Active Org.- |
Originator Org.- |
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
金茵利胆颗粒治疗慢性胆囊炎(湿热证)的有效性和安全性的随机、双盲、剂量平行对照、多中心临床试验研究
[Translation] A randomized, double-blind, dose-controlled, multicenter clinical trial on the efficacy and safety of Jinyinlidan Granules in the treatment of chronic cholecystitis (damp-heat syndrome)
客观评价金茵利胆颗粒的有效性及安全性,探索III期临床试验最佳给药剂量
[Translation] Objectively evaluate the effectiveness and safety of Jinyinlidan Granules and explore the optimal dosage for Phase III clinical trials
100 Clinical Results associated with Chongqing Sanuo Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Chongqing Sanuo Pharmaceutical Co., Ltd.
100 Deals associated with Chongqing Sanuo Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Chongqing Sanuo Pharmaceutical Co., Ltd.